Trial on S-ICD Implantation Without Defibrillation Testing Shows Non-Inferiority
A randomized trial is assessing whether S-ICD implantation without defibrillation testing is non-inferior to the standard method.
Asset / Drug
Drug and asset intelligence for Medtronic with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Device Therapy
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.